除細動器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の除細動器の市場規模は、2023年に101億9,000万米ドル、2030年までに122億4,000万米ドルに達し、2024年～2030年の予測期間にCAGRで3.11％の成長が見込まれます。除細動器の需要は主に、心臓疾患の罹患率の増加、先進技術の統合、政府と民間メーカーによる投資の増加、心血管疾患と除細動器の使用に関する意識向上プログラムなどの高まりと関連しています。

除細動器の市場力学

心房細動は、不規則で急速な心拍数を特徴とし、高齢者や高血圧、肥満、心臓疾患などの慢性疾患を患う人々において、脳卒中、心不全、その他の心臓関連合併症のリスクを高める可能性があります。NCBI 2022で発表された研究によると、心房細動はもっとも頻度の高い心臓不整脈であり、2017年の心房細動の世界の発症数は304万6,000人と記録されています。さらに、WHOの2022年の報告によると、心血管疾患による死亡の85％は心臓発作と脳卒中によるものです。除細動器は、心臓に電気ショックを送ることで正常な心拍を回復させるための装置であり、不整脈を修正または予防するために使用されます。そのため、心臓関連疾患の罹患率の増加は、除細動器に対する需要を喚起する可能性が高いです。

さらに、簡素化された植込み技術、小型化、心臓に植込まれるリード線の削減または排除を備えたいくつかの新しいデバイスの導入も、除細動器市場を強化すると予測されています。例えば、2019年にBiotronikは新しいICDと心臓再同期療法除細動器（CRT-D）のActicorデバイスファミリーを発売し、ハイブリッドICD Acticorシステムは心房リードを必要とせずにデュアルチャンバーの診断を提供します。

しかし、突然の心停止に対する早期の是正措置に関する認識不足などの特定の要因が、除細動器市場の成長に小さなハードルをもたらすと予測されます。

除細動器市場のセグメント分析

製品タイプ別の除細動器市場では、ICD（植込み式除細動器）が市場で最大のシェアを占めると予測されます。ICDには、ワンチャンバー型、デュアルチャンバー型、皮下ICD、磁気共鳴画像（MRI）セーフICDなどのさまざまなタイプがあります。例えば、除細動器の分野で近年開発されたS-ICDは、従来のICDや経静脈的ICDに比べて多くの利点があります。主な利点としては、血管損傷や気胸のリスクが低いこと、リード線がないため、先天性心疾患のある小児や静脈からICDを挿入できない患者に最適であることなどが挙げられます。また、このデバイスは従来の経静脈的ICDよりも忍容性が高いため、今後数年間のICDの需要を高めます。

加えて、規制当局による新製品の承認も市場を急成長させると予測されます。例えば、近年2018年に、AbbottはQuadra Assura MP CRT-DとFortify Assura ICDのMR条件付き表示についてFDAの承認を受けました。さらに同社は、同社のもっとも広く使用されているICDと関連する高電圧リードの1つであるEllipse ICDのMR条件付き表示についてFDAの認可を受けています。このため、主要企業による必須医療機器の製造の増加とともに、近年の製品承認が除細動器市場の成長に寄与すると予測されています。

北米が除細動器市場全体を独占すると予測されます。

すべての地域の中で、北米が予測期間に除細動器市場全体を独占すると予測されます。この独占は、心血管疾患の有病率の増加、よりよい医療インフラへのアクセス、同地域における主要市場企業のプレゼンスによるものです。また、植込み式デバイスの費用や手技をカバーする支援的な償還プログラムも、同地域でこうしたデバイスを選択する人々をさらに後押ししています。

さらに米国では、心血管疾患に罹患するリスクが劇的に増加しています。CDCによると、2020年、心臓病は米国のほとんどの男女の死因の第1位であり、米国では毎年約65万5,000人の米国人が心臓病で死亡しています。同地域における心血管疾患への関心の高まりが市場を押し上げると予測されます。さらに、地域におけるStryker、Abbott、Boston Scientific Corporationなどの主要メーカーのプレゼンスにより、ICDと体外式除細動器の両分野における提携、製品発売、合併買収などを含むさまざまな商業化活動により市場が急成長し、同地域の市場を活性化させると予測されています。

当レポートでは、世界の除細動器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 除細動器市場レポートのイントロダクション

第2章 除細動器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 除細動器市場の主な要因の分析

• 除細動器市場の促進要因
  • 心血管疾患の有病率の上昇
  • 除細動器部門における技術の進歩
  • 政府と民間メーカーによる投資の増
  • 心血管障害に関する意識向上プログラム
• 除細動器市場の抑制要因と課題
  • 厳しい規制
  • 製品リコールの削減
• 除細動器市場の機会
  • 市場参入企業による技術開発への投資の増加
  • 新興国における成長機会

第5章 除細動器ポーターのファイブフォース分析

第6章 除細動器市場レイアウト

• 製品タイプ別
  • 植込み式除細動器
  • 体外式除細動器
• エンドユーザー別
  • 病院
  • 外来手術センター
  • 在宅ケア環境
  • その他
• 地域別
  • 北米の除細動器の市場規模（2021年～2030年）
  • 欧州の除細動器の市場規模（2021年～2030年）
  • アジア太平洋の除細動器の市場規模（2021年～2030年）
  • その他の地域の除細動器の市場規模（2021年～2030年）

第7章 除細動器の企業と製品のプロファイル

• Abbott
• Medtronic
• Boston Scientific Corporation
• Stryker
• Koninklijke Philips N.V
• Zoll Medical Corporation
• Microport Scientific Corporation
• LivaNova PLC
• Biotronik, Inc.
• Nihon Kohden Corporation
• SCHILLER AG
• Bexen Cardio
• Progetti S.r.l.
• BPL Medical Technologies
• Shenzhen Comen Medical Instruments Co., Ltd.

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 免責事項

第12章 DelveInsightについて

List of Tables

• Table 1: Competitive Analysis
• Table 2: Defibrillators Market in Global (2021-2030)
• Table 3: Defribillators Market in Global by Product Type (2021-2030)
• Table 4: Defribillators Market in Global by End-User (2021-2030)
• Table 5: Defribillators Market in Global by Geography (2021-2030)
• Table 6: Defibrillators Market in North America (2021-2030)
• Table 7: Defribillators Market in the US (2021-2030)
• Table 8: Defribillators Market in Canada (2021-2030)
• Table 9: Defribillators Market in Mexico (2021-2030)
• Table 10: Defribillators Market in Europe (2021-2030)
• Table 11: Defribillators Market in France (2021-2030)
• Table 12: Defribillators Market in Germany (2021-2030)
• Table 13: Defribillators Market in the United Kingdom (2021-2030)
• Table 14: Defribillators Market in Italy (2021-2030)
• Table 15: Defribillators Market in Spain (2021-2030)
• Table 16: Defribillators Market in Rest of Europe (2021-2030)
• Table 17: Defribillators Market in Asia-Pacific (2021-2030)
• Table 18: Defribillators Market in China (2021-2030)
• Table 19: Defribillators Market in Japan (2021-2030)
• Table 20: Defribillators Market in India (2021-2030)
• Table 21: Defribillators Market in Australia (2021-2030)
• Table 22: Defribillators Market in South Korea (2021-2030)
• Table 23: Defribillators Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Defribillators Market in the Rest of the World (2021-2030)
• Table 25: Defribillators Market in the Middle East (2021-2030)
• Table 26: Defribillators Market in Africa (2021-2030)
• Table 27: Defribillators Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Defribillators Market in Global (2021-2030)
• Figure 3: Defribillators Market in Global by Product Type (2021-2030)
• Figure 4: Defribillators Market in Global by End-User (2021-2030)
• Figure 5: Defribillators Market in Global by Geography (2021-2030)
• Figure 6: Defribillators Market in North America (2021-2030)
• Figure 7: Defribillators Market in the US (2021-2030)
• Figure 8: Defribillators Market in Canada (2021-2030)
• Figure 9: Defribillators Market in Mexico (2021-2030)
• Figure 10: Defribillators Market in Europe (2021-2030)
• Figure 11: Defribillators Market in France (2021-2030)
• Figure 12: Defribillators Market in Germany (2021-2030)
• Figure 13: Defribillators Market in the United Kingdom (2021-2030)
• Figure 14: Defribillators Market in Italy (2021-2030)
• Figure 15: Defribillators Market in Spain (2021-2030)
• Figure 16: Defribillators Market in Rest of Europe (2021-2030)
• Figure 17: Defribillators Market in Asia-Pacific (2021-2030)
• Figure 18: Defribillators Market in China (2021-2030)
• Figure 19: Defribillators Market in Japan (2021-2030)
• Figure 20: Defribillators Market in India (2021-2030)
• Figure 21: Defribillators Market in Australia (2021-2030)
• Figure 22: Defribillators Market in South Korea (2021-2030)
• Figure 23: Defribillators Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Defribillators Market in the Rest of the World (2021-2030)
• Figure 25: Defribillators Market in the Middle East (2021-2030)
• Figure 26: Defribillators Market in Africa (2021-2030)
• Figure 27: Defribillators Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER's Five Force Analysis

Defibrillators Market By Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centres, Homecare Settings, and Others), Geography is projected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of cardiac disorders and integration of advanced technology

Global Defibrillators Market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2024 to 2030, to reach USD 12.24 billion by 2030. The demand for defibrillators is primarily associated with the growing incidence of cardiac disorders, integration of advanced technology, increasing investments by government and private manufacturers, and rising awareness programs regarding cardiovascular disorders and the usage of defibrillators, among others.

Defibrillators Market Dynamics:

Atrial fibrillation which is characterized by an irregular and most often rapid heart rate can increase the risk of stroke, heart failure, and other heart-related complications in the old aged population and individuals suffering chronic conditions such as high blood pressure, obesity, and heart disorders. According to a study published in NCBI 2022, atrial fibrillation is the most frequent cardiac arrhythmia, and the worldwide incidence of atrial fibrillation in 2017 was registered to be 3.046 million. Moreover, as per the WHO 2022 report, 85% of all cardiovascular deaths are due to heart attacks and stroke. Defibrillators are devices used to restore a normal heartbeat by sending an electric shock to the heart and are used to correct or prevent arrhythmias. Therefore, the rising incidence of heart-associated disorders is likely to shoot the demand for defibrillators.

Further, the introduction of several new devices with simplified implantation technology, smaller size, and reducing or eliminating leads implanted in the heart is also anticipated to augment the market for defibrillators. For instance, in 2019, Biotronik launched the Acticor device family of new ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds), the hybrid ICD Acticor systems offer dual-chamber diagnostics without the need for an atrial lead.

However, certain factors such as lack of awareness regarding early corrective measures for sudden cardiac arrest are anticipated to pose a minor hurdle for the growth of the defibrillators market.

Defibrillators Market Segment Analysis:

Defibrillator Market By Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Defibrillators product type segment, ICD (Implantable Cardioverter Defibrillator) is expected to hold the largest share in the market as there are different types of ICDs such as one-chambered, dual-chambered ICDs, subcutaneous ICDs, and magnetic resonance imaging (MRI)-safe ICDs available in the market. For instance, S-ICDs which are a recent development in the field of defibrillators have many advantages over traditional or transvenous ICDs. These mainly include lower risk of vascular injury or pneumothorax, the absence of leads is the main advantage making it a great alternative for children with congenital heart diseases or patients with no venous access who were unsuitable for transvenous ICD. Also, the device is more well tolerated than the traditional (transvenous) ICDs thereby raising the demand for ICDs in the coming years.

In addition, new product approvals in the market by regulatory bodies are also expected to surge the market. For instance, recently in the year 2018, Abbott received FDA approval for the MR-conditional labeling for the Quadra Assura MP CRT-D and Fortify Assura ICD. Moreover, the same company has received FDA clearance for MR-conditional labeling for one of the company's most widely used ICDs and associated high-voltage leads - the Ellipse ICD. Therefore, recent product approvals along with increased manufacturing of essential medical devices by key players are the factors expected to contribute to the defibrillators market growth.

North America is expected to dominate the overall Defibrillators Market:

Among all the regions, North America is expected to dominate the overall Defibrillator market during the forecast period. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region. Also, the supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.

Further, in the United States, the risk of being affected by cardiovascular disease is increasing dramatically. According to the CDC, in 2020, heart disease was the leading cause of death among most men and women in the United States and about 655,000 Americans died from heart disease each year in the region. The rising concern about cardiovascular disorders in the region is expected to boost the market. Furthermore, the presence of key manufacturers in the region such as Stryker, Abbott, and Boston Scientific Corporation, among others in the region will surge the market due to various commercialization activities including collaborations, product launches, merger acquisitions, and others in the field of both ICDs and External defibrillator is projected to fuel the market in the region. For instance, in 2019, Stryker launched LIFEPAK® CR2 Defibrillator with LIFELINK central(TM) AED Program Manager in the United States. Moreover, the rising installation of external defibrillators in public places apart from hospitals aiming to prevent sudden cardiac arrest is also a prominent factor contributing to the market growth. Hence, all these factors along with product launches are propelling the defibrillators market.

Europe and Asia-Pacific region have a future potential growth in the global defibrillators market. This is due to the rising burden of cardiovascular diseases in the European region countries and Asia countries also. The rising healthcare costs, improving healthcare infrastructure, and increase in disposable income in growing economies such as China, and India, among others are other factors that boost the market. In addition, countries such as Japan have a high penetration of defibrillators due to the presence of giant companies that are focused on expanding the market in other geographies is also likely to augment the global defibrillators market.

Defibrillators Market Key Players:

Some of the key market players operating in the Defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; Stryker; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik, Inc.; Nihon Kohden Corporation, and others.

Recent Developmental Activities in Defibrillators Market:

In July 2020, Phillips received 510(k) clearances from the FDA for its professional defibrillator (Tempus LS- Manual), offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S.

In June 2020, ZOLL® Medical Corporation, an Asahi Kasei Group Company received premarket approval (PMA) for its ZOLL AED 3® defibrillator with enhanced real CPR help, integrated child rescue, and wireless connectivity.

In February 2020, Abbott received CE Mark for the new Gallant(TM) implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices offer new opportunities for patient engagement and remote monitoring through new smartphone connectivity and connected applications. Additional benefits include a patient-preferred design, improved battery longevity, and MRI compatibility.

Key Takeaways from the Defibrillators Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Defibrillators market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Defibrillators Market.

Various opportunities available for the other competitor in the Defibrillators Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Defibrillators market growth in the coming future?

Target Audience who can be benefited from Defibrillators Market Report Study

Defibrillators providers

Research organizations and consulting companies

Defibrillators-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Defibrillators

Various End-users who want to know more about the Defibrillators Market and the latest technological developments in the Defibrillators market.

Frequently Asked Questions for Defibrillators Market:

What are Defibrillators?

Defibrillators are devices that give a high-energy electric shock to the heart of an individual who suffers a cardiac arrest. These can be implantable, external, and wearable based on their modality.

What is the market for Global Defibrillators?

Global Defibrillator Market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2024 to 2030, to reach USD 12.24 billion by 2030.

What are the drivers for Global Defibrillators Market?

The major factors responsible for driving the defibrillators market are the increasing prevalence of cardiac disorders, growing public-private investment in developing new and technologically advanced products, and rising awareness associated with defibrillators in cardiac-associated diseases in many countries.

What are the key players operating in Global Defibrillators Market?

Some of the key market players operating in the Defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; Stryker; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik, Inc.; Nihon Kohden Corporation, and others.

What region has the highest share in the Defibrillators market?

North America is expected to dominate the overall Defibrillator market during the forecast period, 2024-2030 owing to the growing prevalence of cardiovascular diseases, access to improved healthcare infrastructure coupled with the presence of major market players in the region. Moreover, enhanced reimbursement programs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.

Table of Contents

1. Defibrillators Market Report Introduction

2. Defibrillators Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at a Glance
• 2.3 Competitive Assessment

3. Regulatory Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Defibrillators Market Key Factors Analysis

• 4.1 Defibrillators Market Drivers
  • 4.1.1 Rising Prevalence of Cardiovascular Diseases
  • 4.1.2 Technological Advancements in the Field of Defibrillators
  • 4.1.3 Increasing Investments by Government and private manufacturers
  • 4.1.4 Rising awareness programs regarding cardiovascular disorders
• 4.2 Defibrillators Market Restraints and Challenges
  • 4.2.1 Stringent Regulations
  • 4.2.2 Fewer Product Recalls
• 4.3 Defibrillators Market Opportunities
  • 4.3.1 Rise in Investment by market players for technological development
  • 4.3.2 Growth Opportunities in Emerging Nations

5. Defibrillators Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. Defibrillators Market layout

• 6.1 By Product Type
  • 6.1.1 Implantable Cardioverter Defibrillators
    • 6.1.1.1 Single Chamber ICDs
    • 6.1.1.2 Dual Chamber ICDs
    • 6.1.1.3 Subcutaneous ICDs (S-ICD)
    • 6.1.1.4 CRT-D
  • 6.1.2 External Defibrillators
    • 6.1.2.1 Semi-Automated
    • 6.1.2.2 Automated
    • 6.1.2.3 Wearable
• 6.2 By End-User
  • 6.2.1 Hospitals
  • 6.2.2 Ambulatory Surgical Centers
  • 6.2.3 Home Care Settings
  • 6.2.4 Others
• 6.3 By Geography
  • 6.3.1 North America Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.1.1 United States Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.1.2 Canada Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.1.3 Mexico Defibrillators Market Size in USD Million (2021-2030)
  • 6.3.2 Europe Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2.1 France Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2.2 Germany Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2.3 United Kingdom Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2.4 Italy Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2.5 Spain Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2.6 Rest of Europe Defibrillators Market Size in USD Million (2021-2030)
  • 6.3.3 Asia-Pacific Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3.1 China Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3.2 Japan Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3.3 India Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3.4 Australia Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3.5 South Korea Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3.6 Rest of Asia-Pacific Defibrillators Market Size in USD Million (2021-2030)
  • 6.3.4 Rest of the World (RoW) Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.4.1 Middle East Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.4.2 Africa Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.4.3 South America Defibrillators Market Size in USD Million (2021-2030)

7. Defibrillators Company and Product Profiles

• 7.1 Abbott
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2 Medtronic
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3 Boston Scientific Corporation
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4 Stryker
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5 Koninklijke Philips N.V
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6 Zoll Medical Corporation
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7 Microport Scientific Corporation
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8 LivaNova PLC
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9 Biotronik, Inc.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10 Nihon Kohden Corporation
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11 SCHILLER AG
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12 Bexen Cardio
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13 Progetti S.r.l.
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14 BPL Medical Technologies
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15 Shenzhen Comen Medical Instruments Co., Ltd.
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight